Residues in the C-terminal region of activin A determine specificity for follistatin and type II receptor binding
in Journal of EndocrinologySearch for other papers by WH Fischer in
Current site
Google Scholar
PubMed
Search for other papers by M Park in
Current site
Google Scholar
PubMed
Search for other papers by C Donaldson in
Current site
Google Scholar
PubMed
Search for other papers by E Wiater in
Current site
Google Scholar
PubMed
Search for other papers by J Vaughan in
Current site
Google Scholar
PubMed
Search for other papers by LM Bilezikjian in
Current site
Google Scholar
PubMed
Search for other papers by W Vale in
Current site
Google Scholar
PubMed
Activin is a secreted growth factor that signals by binding two related classes of single transmembrane receptors at the cell surface. The interaction of activin with its receptors is highly regulated by other cell surface receptors, antagonistic ligands, and high affinity extracellular binding proteins such as follistatin. Two activin A mutants, the deletion mutant des[85-109]-activin A and the point mutant K102E-activin A (K102E), were investigated with respect to their ability to bind cell surface receptors and the binding protein follistatin. The deletion mutant exhibits low affinity for both receptors and follistatin whereas the point mutant fails to bind cell surface receptors but binds follistatin-288 with high affinity. K102E is able to compete with wild type activin to bind to follistatin and can thus increase the concentration of activin available for receptor binding and signaling. These findings underline the importance of the C-terminal region of activin for binding interactions and show that different residues in this region are involved in cell surface receptor and follistatin interactions.
Journal of Endocrinology is committed to supporting researchers in demonstrating the impact of their articles published in the journal.
The two types of article metrics we measure are (i) more traditional full-text views and pdf downloads, and (ii) Altmetric data, which shows the wider impact of articles in a range of non-traditional sources, such as social media.
More information is on the Reasons to publish page.
| Sept 2018 onwards | Past Year | Past 30 Days | |
|---|---|---|---|
| Full Text Views | 120 | 39 | 12 |
| PDF Downloads | 100 | 26 | 1 |
Online ISSN: 1479-6805
Print ISSN: 0022-0795
Strengthening biomedical communities
to advance science and health
CONTACT US
Bioscientifica Ltd | Starling House | 1600 Bristol Parkway North | Bristol BS34 8YU | UK
Bioscientifica Ltd | Registered in England no 3190519